4D Molecular Therapeutics Inc (FDMT)
7.975
-0.44
(-5.17%)
USD |
NASDAQ |
Nov 21, 16:00
7.975
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Price to Book Value: 0.6667 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.7031 |
| November 19, 2024 | 0.7248 |
| November 18, 2024 | 0.6956 |
| November 15, 2024 | 0.7382 |
| November 14, 2024 | 0.6705 |
| November 13, 2024 | 0.6446 |
| November 12, 2024 | 0.658 |
| November 11, 2024 | 0.7589 |
| November 08, 2024 | 0.7636 |
| November 07, 2024 | 0.7786 |
| November 06, 2024 | 0.7852 |
| November 05, 2024 | 0.789 |
| November 04, 2024 | 0.7687 |
| November 01, 2024 | 0.7612 |
| October 31, 2024 | 0.7532 |
| October 30, 2024 | 0.7777 |
| October 29, 2024 | 0.7711 |
| October 28, 2024 | 0.8059 |
| October 25, 2024 | 0.7664 |
| October 24, 2024 | 0.772 |
| October 23, 2024 | 0.8002 |
| October 22, 2024 | 0.7767 |
| October 21, 2024 | 0.8068 |
| October 18, 2024 | 0.8021 |
| October 17, 2024 | 0.7946 |
| Date | Value |
|---|---|
| October 16, 2024 | 0.8143 |
| October 15, 2024 | 0.836 |
| October 14, 2024 | 0.8491 |
| October 11, 2024 | 0.8623 |
| October 10, 2024 | 0.8209 |
| October 09, 2024 | 0.8463 |
| October 08, 2024 | 0.8821 |
| October 07, 2024 | 0.8708 |
| October 04, 2024 | 0.9375 |
| October 03, 2024 | 0.9723 |
| October 02, 2024 | 0.9657 |
| October 01, 2024 | 0.9789 |
| September 30, 2024 | 1.016 |
| September 27, 2024 | 0.9566 |
| September 26, 2024 | 0.9681 |
| September 25, 2024 | 0.9964 |
| September 24, 2024 | 1.015 |
| September 23, 2024 | 1.026 |
| September 20, 2024 | 1.051 |
| September 19, 2024 | 1.192 |
| September 18, 2024 | 1.486 |
| September 17, 2024 | 1.428 |
| September 16, 2024 | 1.456 |
| September 13, 2024 | 1.435 |
| September 12, 2024 | 1.405 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6197
Minimum
Jun 16 2022
17.88
Maximum
Dec 18 2020
2.605
Average
2.386
Median
Jan 18 2024
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 2.790 |
| Ocular Therapeutix Inc | 3.803 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
Price to Book Value Related Metrics
| PS Ratio | 23804.95 |
| PEG Ratio | -0.6366 |
| Price | 7.975 |
| Earnings Yield | -35.74% |
| Market Cap | 368.67M |
| PEGY Ratio | -0.6366 |